SearchDictionaryMobileLogin

Shy-Drager Syndrome

120  relevant articles (3 outcomes, 5 trials/studies) found for this Disease

Description: A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with ORTHOSTASIS and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p536)

Also Known As:
Dysautonomia-Orthostatic Hypotension Syndrome; Syndrome, Dysautonomia-Orthostatic Hypotension; Autonomic Failures, Progressive; Dysautonomia Orthostatic Hypotension Syndrome; Dysautonomia-Orthostatic Hypotension Syndromes; Dysautonomic Orthostatic Hypotension; Dysautonomic Orthostatic Hypotensions; Failure, Progressive Autonomic; Failures, Progressive Autonomic; Hypotension Syndrome, Dysautonomia-Orthostatic; Hypotension Syndromes, Dysautonomia-Orthostatic; Hypotension, Dysautonomic Orthostatic; Hypotensions, Dysautonomic Orthostatic; Idiopathic Orthostatic Hypotension, Shy Drager Type; Orthostatic Hypotensions, Dysautonomic; Progressive Autonomic Failure; Progressive Autonomic Failures; Shy Drager Syndrome; Syndrome, Dysautonomia Orthostatic Hypotension; Syndrome, Shy-Drager; Syndromes, Dysautonomia-Orthostatic Hypotension; Autonomic Failure, Progressive; Idiopathic Orthostatic Hypotension, Shy-Drager Type; Orthostatic Hypotension, Dysautonomic

Relationship Network

Disease Context: Research Results

Related Diseases

1. Orthostatic Hypotension (Postural Hypotension)
2. Multiple System Atrophy
3. Parkinson Disease (Parkinson's Disease)
4. Syndrome
5. Hypertension (High Blood Pressure)

Experts

1. Shigematsu, Kenji: 1 article (07/2005)
2. Higa, Kazuo: 1 article (07/2005)
3. Shono, Shinjiro: 1 article (07/2005)
4. Hamada, Takamitsu: 1 article (07/2005)
5. Vallejo, Ricardo: 1 article (07/2002)
6. DeSouza, Gerard: 1 article (07/2002)
7. Lee, Jong: 1 article (07/2002)
8. Hanaoka, K: 1 article (01/2001)
9. Hashimoto, H: 1 article (01/2001)
10. Nakajima, H: 1 article (01/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Shy-Drager Syndrome:
1. Propranolol (Inderal)FDA LinkGeneric
2. Midodrine (Midon)FDA LinkGeneric
3. Trimethaphan (Trimetaphan)IBA
4. Norepinephrine (Noradrenaline)FDA LinkGeneric
5. Dopamine (Intropin)FDA LinkGeneric
6. SASIBA
7. Dopamine Agonists (Dopamine Agonist)IBA
8. XenonIBA
9. GABA-A Receptors (GABA(A) Receptor)IBA
10. LisurideIBA

Therapies and Procedures

1. Anesthesia
2. Denervation
3. General Anesthesia
4. Sympathectomy (Sympathectomies)
5. Transplants (Transplant)

Best Treatments:
Research Summary Report
on Shy-Drager Syndrome
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 3 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface